Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVATRAN: Eplerenone for Arterial Stiffness in Kidney Transplant Patients
NCT04450953Phase 3Recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2021
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of eplerenone in arterial stiffness, sponsored by CHRU de Nancy - Hôpital Central. Started Oct 2021; status: recruiting.
02
Drugs
eplerenone
03
Conditions
arterial stiffness
Beyond the preview
Go deeper on NCT04450953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04450953.